甘建辉, 陈杰, 张景华, 郭东勇, 高鲁渤, 邓迺封. 用贺斯替代异体输血对肿瘤患者围术期免疫系统的影响[J]. 中国肿瘤临床, 2005, 32(15): 861-863.
引用本文: 甘建辉, 陈杰, 张景华, 郭东勇, 高鲁渤, 邓迺封. 用贺斯替代异体输血对肿瘤患者围术期免疫系统的影响[J]. 中国肿瘤临床, 2005, 32(15): 861-863.
Gan Jian-hui, Chen Jie, Zhang Jing-hua, . Effect of Hydroxyethylstarch Replacing Xenogenous Blood Tranfusion on Perioperative Immune System in Patients with Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(15): 861-863.
Citation: Gan Jian-hui, Chen Jie, Zhang Jing-hua, . Effect of Hydroxyethylstarch Replacing Xenogenous Blood Tranfusion on Perioperative Immune System in Patients with Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(15): 861-863.

用贺斯替代异体输血对肿瘤患者围术期免疫系统的影响

Effect of Hydroxyethylstarch Replacing Xenogenous Blood Tranfusion on Perioperative Immune System in Patients with Cancer

  • 摘要: 目的:探讨用血浆代用品6%贺斯(HAES)替代异体输血对肿瘤患者围术期免疫系统的影响。方法:将60例恶性肿瘤切除术患者,随机分为两组:输血组30例(B组);输贺斯组30例(H组)。分别于麻醉诱导前,术后第3天及第7天抽取患者外周静脉血,应用酶联免疫吸附法(ELISA)进行细胞因子sIL-2R和IL-2浓度的测定并以乳酸脱氢酶释放法进行NK细胞活性的检测。结果:sIL-2R两组均上升B组更为明显,差异显著(P<0.05);IL-2和NK细胞活性B组术后均明显下降(P<0.05),H组手术前后比较均无明显变化。结论:术中输异体血后抑制患者体内抗肿瘤免疫系统;而输贺斯则对体内抗肿瘤免疫系统无不良影响。

     

    Abstract: Objective : To investigate the effect of 6% hydroxyethylstarch replacing xenogenous blood tranfusion on perioperative immune system in patients with cancer. Methods : Sixty patients who underwent malignant tumor resection were randomly divided into two groups. In group B 30 patients were treated with blood transfusion and in group B 30 patients received hydroxyethylstarch infusion during surgery. The blood samples were collected before anesthesia and on the 3rd,7th day after operation. Enzyme-linKed immunosorbent assay (ELISA) is used to dected the level of sIL-2R and IL-2, the cytoactive of NK cell were measured by the method of LDH release. Results : sIL-2R increased in two group, but the amount of sIL-2R was markedly increased in group B, on the 3rd and 7th day after operation (P<0.05); Il- 2 and the cytoactive of NK cell were markedly decreased after operation in group B(P<0.05), while there was not significant difference in group B. Conclusion : Perioperative xenogenous blood transfusion can depress immune system in patients with cancer, hydroxyethylstarch did not affect immune system.

     

/

返回文章
返回